Ono Pharmaceutical Co (TSE:4528) Cyclically Adjusted FCF per Share: 円137.28 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4528 Ono Pharmaceutical Co Ltd TSE:4528
89 GF Score
Price 円2,405.00
GF Value 円2,234.65
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Ono Pharmaceutical Co Cyclically Adjusted FCF per Share?

Ono Pharmaceutical Co TSE:4528 +0.33% 89 Cyclically Adjusted FCF per Share is 円137.28 as of Mar. 2026. GuruFocus rates TSE:4528 with a GF Score™ of 89/100 and a GF Value™ of 円2,234.65 (Fairly Valued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Ono Pharmaceutical Co's adjusted free cash flow per share for the three months ended in Mar. 2026 was 円103.968. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is 円137.28 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Ono Pharmaceutical Co's average Cyclically Adjusted FCF Growth Rate was 16.80% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 19.50% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 25.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Ono Pharmaceutical Co was 29.50% per year. The lowest was 17.80% per year. And the median was 22.20% per year.

As of today (2026-07-22), Ono Pharmaceutical Co's current stock price is 円2405.00. Ono Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was 円137.28. Ono Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is 17.52.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Ono Pharmaceutical Co was 133.14. The lowest was 12.77. And the median was 56.31.


Ono Pharmaceutical Co  (TSE:4528) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Ono Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=2405.00/137.28
=17.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Ono Pharmaceutical Co was 133.14. The lowest was 12.77. And the median was 56.31.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Ono Pharmaceutical Co Cyclically Adjusted FCF per Share Related Terms


Ono Pharmaceutical Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Ono Pharmaceutical Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ono Pharmaceutical Co Cyclically Adjusted FCF per Share Chart

Ono Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 54.17 80.35 98.12 117.56 137.28

Ono Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 117.56 109.28 120.19 128.31 137.28

TSE:4528 vs LLY, JNJ, ABBV: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - General subindustry, Ono Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ono Pharmaceutical Co Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ono Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Ono Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.


TSE:4528
89GF Score
Ono Pharmaceutical Co Ltd TSE:4528
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ono Pharmaceutical Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ono Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=103.968/112.7000*112.7000
=103.968

Current CPI (Mar. 2026) = 112.7000.

Ono Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -13.744 98.100 -15.789
201609 26.334 98.000 30.284
201612 21.053 98.400 24.113
201703 61.389 98.100 70.525
201706 -49.362 98.500 -56.478
201709 3.193 98.800 3.642
201712 -13.587 99.400 -15.405
201803 33.574 99.200 38.143
201806 9.048 99.200 10.279
201809 28.594 99.900 32.258
201812 11.414 99.700 12.902
201903 23.239 99.700 26.269
201906 -0.717 99.800 -0.810
201909 42.379 100.100 47.713
201912 20.581 100.500 23.079
202003 40.944 100.300 46.006
202006 13.510 99.900 15.241
202009 36.588 99.900 41.276
202012 15.264 99.300 17.324
202103 42.177 99.900 47.581
202106 0.923 99.500 1.045
202109 62.649 100.100 70.535
202112 -29.247 100.100 -32.928
202203 66.048 101.100 73.626
202206 60.010 101.800 66.435
202209 94.750 103.100 103.573
202212 60.298 104.100 65.279
202303 82.088 104.400 88.614
202306 -35.588 105.200 -38.125
202309 93.421 106.200 99.139
202312 49.124 106.800 51.838
202403 81.725 107.200 85.918
202406 -4.174 108.200 -4.348
202409 67.927 108.900 70.297
202412 15.153 110.700 15.427
202503 79.592 111.100 80.738
202506 -94.984 111.700 -95.834
202509 104.716 112.000 105.370
202512 64.204 113.000 64.034
202603 103.968 112.700 103.968

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of 円137.28 mean?
Ono Pharmaceutical Co (TSE:4528) has a Cyclically Adjusted FCF per Share of 円137.28 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Ono Pharmaceutical Co and its competitors.
Is Ono Pharmaceutical Co's Cyclically Adjusted FCF per Share too high?
Ono Pharmaceutical Co's current Cyclically Adjusted FCF per Share is 円137.28. Overall, Ono Pharmaceutical Co has a GF Score™ of 89/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ono Pharmaceutical Co's Cyclically Adjusted FCF per Share compare to LLY and JNJ?
Ono Pharmaceutical Co's Cyclically Adjusted FCF per Share of 円137.28 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Ono Pharmaceutical Co and its competitors. Ono Pharmaceutical Co's current Cyclically Adjusted FCF per Share is 円137.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ono Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Ono Pharmaceutical Co (TSE:4528) is currently considered Fairly Valued. The stock's GF Value™ is 円2,234.65, compared to a current price of 円2,405.00 — trading 7.6% above its estimated fair value. The current Cyclically Adjusted FCF per Share is 円137.28. Ono Pharmaceutical Co's overall GF Score™ is 89/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Ono Pharmaceutical Co (TSE:4528), the current Cyclically Adjusted FCF per Share is 円137.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ono Pharmaceutical Co (TSE:4528) Overvalued in 2026?

Based on GuruFocus' analysis, Ono Pharmaceutical Co stock appears to be overvalued. The current stock price of 円2,405.00 is trading 7.6% above its estimated GF Value™ of 円2,234.65. GuruFocus considers Ono Pharmaceutical Co to be Fairly Valued.

Key valuation signals for TSE:4528:

  • Cyclically Adjusted FCF per Share: 円137.28
  • GF Value™: 円2,234.65 vs. price of 円2,405.00 (7.6% above fair value)
  • GF Score™: 89/100 with 4 warning signs

No single metric tells the full story. See the TSE:4528 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ono Pharmaceutical Co Business Description

Other Exchanges OPHLY:USAON4:Germany
Address 1-8-2 Kyutarocho, Chuo-ku, Osaka, JPN, 541-8564
Ono Pharmaceutical Co Ltd is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. The vast majority of the company's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of the company's sales is generated in Japan, followed by the rest of Asia and Europe.
89GF Score

Get the complete analysis for TSE:4528

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,405.00
Price
円2,234.65
GF Value